Health ❯Healthcare

Chronic Conditions

Diabetes Obesity Diabetes Management Asthma Type 2 Diabetes Hypertension Heart Failure Autoimmune Diseases Arthritis Heart Disease Weight Management Comorbidities Post-Acute Sequelae Chronic Kidney Disease Cardiovascular Health Women's Health Inflammatory Bowel Disease Renal Disease Cardiovascular Diseases At-Risk Populations Asthma Management Cancer Complications Immunocompromised Patients Influenza GLP-1 Receptor Agonists Sleep Disorders Lymphedema Diabetes in Pregnancy Kidney Health Diabetic Nephropathy Aging Cardiometabolic Disorders Bronchitis Dental Coverage Lung Disease Diabetes and Cancer Urinary Retention Long COVID Endometriosis COVID-19 Heart Health Obesity Treatment Kidney Disease Osteoporosis Statistics Bone Health Blood Disorders Respiratory Diseases

Amgen Advances Weight-Loss Drug MariTide with Two Phase 3 Trials

Study Finds Paxlovid Offers Limited Benefits for Vaccinated Seniors

FDA Approves Ozempic to Reduce Kidney Disease Risks in Type 2 Diabetes Patients

Stem Cell Heart Patches Show Promise in Early Trials

Stammzell-Herzpflaster Shows Promise for Treating Severe Heart Failure

Study Maps Broad Health Impacts of Popular GLP-1 Weight-Loss Drugs

Medicare Expands Drug Price Negotiations to Include Popular Weight-Loss Medications

Norwegian Queen Sonja Recovering After Successful Pacemaker Surgery

GLP-1 Drugs Revolutionize Obesity Treatment While Raising Questions About Risks and Costs

FDA Ends Shortage of Tirzepatide, Restricts Compounded Weight-Loss Drugs

FDA Approves Zepbound as First Drug Treatment for Sleep Apnea

Growing Demand for Weight-Loss Drugs in the UK Raises Safety and Accessibility Concerns

Experts Explore Potential of Ozempic Microdosing for Health Beyond Weight Loss

Zepbound Outperforms Wegovy in Weight Loss Clinical Trial

NHS to Gradually Roll Out Mounjaro Weight-Loss Drug Over 12 Years

Federal Government Subsidizes First Endometriosis Drug in 30 Years

Navigating Thanksgiving on Weight-Loss Drugs: Expert Advice on Food Choices

UK Doctors Advised to Limit Blue Inhaler Prescriptions Over Environmental and Health Concerns

Diabetes and Obesity Drugs Found to Protect Kidney Health

U.S. Preterm Birth Rates Remain Critically High, New Report Shows

Scotland Faces Health Crisis Linked to Weight-Loss Injections

Nova Scotia Premier Apologizes for Denied Medical Coverage

Germany Faces Medication Shortages Amidst Rising Demand

Canada Enacts Pharmacare Bill for Diabetes and Birth Control Coverage

Whitney Rose's Daughter Hospitalized for Severe Asthma Attack

Wegovy and Ozempic: Celebrity Trends and Health Risks

Semaglutide Shows Promise in Reducing Opioid Overdose Risk, Study Finds

FDA Approves First At-Home Nasal Spray Flu Vaccine

Pfizer's New Drug Shows Promise in Combatting Cancer-Related Weight Loss

Wearable Heart Monitors Improve AFib Detection but Don't Lower Stroke Rates

New Study Confirms Increased Safety in Living Kidney Donations

Semaglutide Shows Significant Cardiovascular Benefits for Heart Failure Patients

European Models Offer Solutions to U.S. Maternal Mortality Crisis

New Study Identifies Distinct Long COVID Symptoms in Children and Adolescents

Routine Lab Tests Ineffective in Diagnosing Long COVID, Study Finds

Researchers Develop 'Smart Insulin' for Improved Diabetes Management

Millions of Americans Using Herbal Supplements Linked to Liver Damage

NHS Approves Groundbreaking Gene-Editing Therapy for Beta Thalassemia

New Osteoporosis Drug Approved for Postmenopausal Women in England

Pharmacists Warn Against Fake Weight-Loss Jabs Amid Ozempic Shortage

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks

FDA Issues Warning on Overdoses from Compounded Semaglutide Injections

Roche Accelerates Development of Promising Weight-Loss Pills

First UK Teen Receives Bladder Pacemaker for Rare Condition

Arvind Kejriwal Receives Insulin in Jail Amid Allegations of Medical Neglect